These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 14621973)

  • 1. Acid-treated yeast cell wall as a binder displaying function of disintegrant.
    Ozeki T; Katsuyama H; Yasuzawa Y; Takashima Y; Kasai T; Eguchi T; Kakiuchi H; Yuasa H; Okada H
    AAPS PharmSciTech; 2003; 4(3):E41. PubMed ID: 14621973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive. II: effects of curing on the medicine release from AYC-coated tablets.
    Yuasa H; Kaneshige J; Ozeki T; Kasai T; Eguchi T; Ishiwaki N
    Int J Pharm; 2000 Nov; 209(1-2):69-77. PubMed ID: 11084247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive I. AYC as a novel coating material.
    Kasai T; Eguchi T; Ishiwaki N; Kaneshige J; Ozeki T; Yuasa H
    Int J Pharm; 2000 Aug; 204(1-2):53-9. PubMed ID: 11011986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextrose monohydrate as a non-animal sourced alternative diluent in high shear wet granulation tablet formulations.
    Mitra B; Wolfe C; Wu SJ
    Drug Dev Ind Pharm; 2018 May; 44(5):817-828. PubMed ID: 29300107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive. III. AYC aqueous coating onto granules and film formation mechanism of AYC.
    Yuasa H; Kaneshige J; Ozeki T; Kasai T; Eguchi T; Ishiwaki N
    Int J Pharm; 2002 Apr; 237(1-2):15-22. PubMed ID: 11955800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionality of wet-granulated disintegrant in comparison to directly incorporated disintegrant in a poorly water-soluble tablet matrix.
    Veronica N; Lee ESM; Heng PWS; Liew CV
    Int J Pharm; 2024 Aug; 661():124467. PubMed ID: 39004293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roll compaction/dry granulation: effect of raw material particle size on granule and tablet properties.
    Herting MG; Kleinebudde P
    Int J Pharm; 2007 Jun; 338(1-2):110-8. PubMed ID: 17324537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous twin screw granulation: influence of process variables on granule and tablet quality.
    Vercruysse J; Córdoba Díaz D; Peeters E; Fonteyne M; Delaet U; Van Assche I; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Sep; 82(1):205-11. PubMed ID: 22687571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of binder properties, method of addition, powder type and operating conditions on fluid-bed melt granulation and resulting tablet properties.
    Abberger T
    Pharmazie; 2001 Dec; 56(12):949-52. PubMed ID: 11802658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and evaluation of nanocrystalline cellulose as a potential disintegrant.
    Wang C; Huang H; Jia M; Jin S; Zhao W; Cha R
    Carbohydr Polym; 2015 Oct; 130():275-9. PubMed ID: 26076627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrusion granulation and high shear granulation of different grades of lactose and highly dosed drugs: a comparative study.
    Keleb EI; Vermeire A; Vervaet C; Remon JP
    Drug Dev Ind Pharm; 2004 Jul; 30(6):679-91. PubMed ID: 15285342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of quality attributes (mechanical strength, disintegration behavior and drug release) of tablets on the basis of characteristics of granules prepared by high shear wet granulation.
    Khan A
    PLoS One; 2021; 16(12):e0261051. PubMed ID: 34882723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of chitosan acetate as a binder for sustained release tablets.
    Nunthanid J; Laungtana-Anan M; Sriamornsak P; Limmatvapirat S; Puttipipatkhachorn S; Lim LY; Khor E
    J Control Release; 2004 Sep; 99(1):15-26. PubMed ID: 15342177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a drug with wax-like properties as a melt binder.
    Dhumal RS; Shimpi SL; Chauhan B; Mahadik KR; Paradkar A
    Acta Pharm; 2006 Dec; 56(4):451-61. PubMed ID: 19839137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemometric evaluation of pharmaceutical properties of antipyrine granules by near-infrared spectroscopy.
    Otsuka M; Mouri Y; Matsuda Y
    AAPS PharmSciTech; 2003; 4(3):E47. PubMed ID: 14621979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified formulations with high drug loads for continuous twin-screw granulation.
    Meier R; Thommes M; Rasenack N; Krumme M; Moll KP; Kleinebudde P
    Int J Pharm; 2015 Dec; 496(1):12-23. PubMed ID: 26024821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
    Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ohike A; Ibuki R; Higaki K; Kimura T
    J Control Release; 2005 Nov; 108(2-3):386-95. PubMed ID: 16253377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of different fast melting disintegrants by means of a central composite design.
    Di Martino P; Martelli S; Wehrlé P
    Drug Dev Ind Pharm; 2005 Jan; 31(1):109-21. PubMed ID: 15704862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
    Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
    Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast-melting tablets based on highly plastic granules.
    Fu Y; Jeong SH; Park K
    J Control Release; 2005 Dec; 109(1-3):203-10. PubMed ID: 16260059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.